
Imricor Medical Systems Inc
ASX:IMR

Intrinsic Value
The intrinsic value of one
IMR
stock under the Base Case scenario is
2.05
AUD.
Compared to the current market price of 1.5 AUD,
Imricor Medical Systems Inc
is
Undervalued by 27%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Imricor Medical Systems Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Imricor Medical Systems Inc
Balance Sheet Decomposition
Imricor Medical Systems Inc
Current Assets | 18.3m |
Cash & Short-Term Investments | 15.7m |
Receivables | 345.3k |
Other Current Assets | 2.3m |
Non-Current Assets | 3.3m |
PP&E | 2.6m |
Other Non-Current Assets | 677.4k |
Free Cash Flow Analysis
Imricor Medical Systems Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Imricor Medical Systems Inc
Revenue
|
959.4k
USD
|
Cost of Revenue
|
-1.9m
USD
|
Gross Profit
|
-924.1k
USD
|
Operating Expenses
|
-15.4m
USD
|
Operating Income
|
-16.3m
USD
|
Other Expenses
|
-13.4m
USD
|
Net Income
|
-29.7m
USD
|
IMR Profitability Score
Profitability Due Diligence
Imricor Medical Systems Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Score
Imricor Medical Systems Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
IMR Solvency Score
Solvency Due Diligence
Imricor Medical Systems Inc's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Score
Imricor Medical Systems Inc's solvency score is 41/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
IMR Price Targets Summary
Imricor Medical Systems Inc
According to Wall Street analysts, the average 1-year price target for
IMR
is 2.33 AUD
with a low forecast of 2.3 AUD and a high forecast of 2.39 AUD.
Dividends
Current shareholder yield for IMR is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
IMR
stock under the Base Case scenario is
2.05
AUD.
Compared to the current market price of 1.5 AUD,
Imricor Medical Systems Inc
is
Undervalued by 27%.